IGNELZI TROY A. (Chief Financial Officer) purchased 55.0% of their position (5.50K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market purchase worth $143.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/21/2026ACC: 0001193125-26-428018
Officer· Chief Financial Officer
Since Feb 2026
+5.50K
Net shares
Net buyer
$143.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.50K
Price / share
$26.10
Trade value
$143.55K
% of position
55.0%
10/21/2026
10K→15.50K
Total
Net shares
+5.50K
Net value
$143.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/21/2026 | P · Purchase | +5.50K | $26.10 | $143.55K | 55.0% | 10K | 15.50K |
| Total | +5.50K | $143.55K | ||||||
Derivative Transactions0
No derivative transactions reported